MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
MDT
87.86
-1.21%↓
VEEV
221.66
-2.12%↓
A
109.71
-5.41%↓
HQY
82.88
-6.59%↓
PDCO
31.2
-0.22%↓
24h
Current
Min
1.5
Max
1.59
Recommendations | Buy |
---|---|
12 Months Forecast | +893.79% upside |
Past performance is not a reliable indicator of future results.
10 Mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Read
10 Mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Read
10 Mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Read
10 Mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Read
10 Mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Read
10 Mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
10 Mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 16 USD 893.79%
High 16 USD
Low 16 USD
Based on 1 Wall Street analysts offering 12 month price targets forFortress Biotech Inc - Dist in the last 3 months.
By TipRanks
Buy
1 ratings
1
Buy
0
Hold
0
Sell
Based on 1 analysts giving stock ratings to Fortress Biotech Inc - Dist in the past 3 months.
$